30.01.2020 • News

Saipem Takes CSI’s Carbon Capture Technology

Saipem Takes CSI’s Carbon Capture Technology (c) Co2 Solutions
Saipem Takes CSI’s Carbon Capture Technology (c) Co2 Solutions

Italian engineering group Saipem has bought carbon dioxide (CO2) capture technology belonging to Canada’s CO2 Solutions (CSI) for an undisclosed sum.

CSI has developed the technology during the past 20 years with support from the Canadian federal and Alberta provincial governments, as well as the EU and US. The technology, said Saipem, is based on a unique enzymatic CO2 capture process that does not use or emit toxic products, can run at scale (30 t/day of CO2) and has been validated by “credible” third parties.

Saipem has also acquired CSI’s portfolio of intellectual property, which consists of more than 90 patents granted or pending and trademarks, along with a CO2 capture unit at a pulp mill in Saint-Felicien, Quebec.

The acquisition will support Saipem’s strategy to help customers manage the energy transition, said Maurizio Coratella, chief operating officer of the company's onshore engineering and construction division. He commented: “The assets and technology purchased will help us expand our green products portfolio and will underpin our resolve to support the industry toward a low carbon energy future.”

CSI explained that the sale to Saipem is part of a court-supervised bankruptcy process. The Superior Court of Quebec approved the sale to the Italian group on Dec. 19, 2019.

A second transaction, which the court approved on Jan. 17, was the sale of a pilot CO2 capture unit to Canadian paraxylene producer Chimie Parachem. The company, owned by Canadian energy firm Suncor and investment group Investissement Quebec, had provided space on its site in Montreal East, Quebec, for CSI’s demonstration unit along with the necessary amenities.

According to the terms of the transaction, Chimie Parachem may resell the facility in the coming months.

 

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.